Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AE

Alex Eberlin — 20 Patents

IPIntercept Pharmaceuticals: 6 patents #5 of 57Top 9%
RPRadius Pharmaceuticals: 6 patents #1 of 15Top 7%
NLNuformix Technologies Limited: 2 patents #3 of 3Top 100%
VIVertex Pharmaceuticals Incorporated: 2 patents #526 of 896Top 60%
AMAmgen: 1 patents #1,873 of 2,867Top 70%
CYCytokinetics: 1 patents #131 of 199Top 70%
APActelion Pharmaceuticals: 1 patents #101 of 188Top 55%
Overall (All Time): #214,803 of 4,157,543Top 6%
20 Patents All Time
Alex Eberlin has been granted 20 US patents while listed as an inventor at Intercept Pharmaceuticals. The first was granted in 2009 and the most recent in August 2025. Alex Eberlin ranks #214,803 of 4,157,543 US inventors in our database (top 5.2%). Patent records list Alex Eberlin in Cambridge, CA, GB.

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12398094 Polymorphic forms of RAD1901-2HCL Michael Paul Cruskie, Jr., Joshua Kyle Bolger, Jonathan Blake McKenzie, Pratik Sheth, Richard Edwards +1 more 2025-08-26
12378227 Therapeutic cocrystals of 3-{[5-(azetidine-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy)-N-(5-methylpyrazin-2-yl)benzamide Christopher Frampton, Joanne Holland 2025-08-05
12319649 Cannabidiolic acid cocrystals Joanne Holland 2025-06-03
12049452 Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical use Joanne Holland 2024-07-30
12012386 Olaparib oxalic acid cocrystals and their pharmaceutical use Joanne Holland, Christopher Frampton 2024-06-18
11708318 Polymorphic forms of RAD1901-2HCL Michael Paul Cruskie, Jr., Joshua Kyle Bolger, Jonathan Blake McKenzie, Pratik Sheth, Richard Edwards +1 more 2023-07-25
11643385 Polymorphic forms of RAD1901-2HCl Michael Paul Cruskie, Jr., Joshua Kyle Bolger, Jonathan Blake McKenzie, Pratik Sheth, Richard Edwards +1 more 2023-05-09
11465969 Salts and crystal forms of omecamtiv mecarbil Henry Morrison, Sheng Cui, Kyle Quasdorf, Evelyn Yanez, Bin Peter Quan +9 more 2022-10-11 $63,047,000
11148996 Polymorphic forms of RAD1901-2HCL Michael Paul Cruskie, Jr., Joshua Kyle Bolger, Jonathan Blake McKenzie, Pratik Sheth, Richard Edwards +1 more 2021-10-19
10745343 Polymorphic forms of RAD1901-2HCl Michael Paul Cruskie, Jr., Joshua Kyle Bolger, Jonathan Blake McKenzie, Pratik Sheth, Richard Edwards +1 more 2020-08-18
10385008 Polymorphic forms of RAD1901-2HCL Michael Paul Cruskie, Jr., Joshua Kyle Bolger, Jonathan Blake McKenzie, Pratik Sheth, Richard Edwards +1 more 2019-08-20
10174073 Preparation and uses of obeticholic acid André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross +2 more 2019-01-08 $40,569,000
10155787 Preparation and uses of obeticholic acid André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross +2 more 2018-12-18 $36,211,000
10047117 Preparation and uses of obeticholic acid André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross +2 more 2018-08-14 $44,186,000
9982008 Preparation and uses of obeticholic acid André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross +2 more 2018-05-29 $28,710,000
9732116 Preparation and uses of obeticholic acid André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross +2 more 2017-08-15 $14,671,000
9238673 Preparation and uses of obeticholic acid André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross +2 more 2016-01-19 $39,616,000
9062014 Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-0-tolyl-thiazolidin-4-one Nicholas Bonham, Stephan Buchmann, Christoph Imboden, Markus Von Raumer 2015-06-23
8153668 Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate Todd Blythe, Michael Laird Hurrey, David Jonaitis, Philip Nyce, Stephan D. Parent +1 more 2012-04-10 $28,818,000
7605270 Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate Todd Blythe, Michael Laird Hurrey, David Jonaitis, Philip Nyce, Stephan D. Parent +1 more 2009-10-20 $31,492,000